Skip to content

Author

Cheng-Yi Mao

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Superior Prognosis of Neoadjuvant Immunochemotherapy over Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Patients with pCR.

BACKGROUND Neoadjuvant chemoradiotherapy (NCRT) is the standard regimen for locally advanced esophageal squamous cell carcinoma (ESCC), while neoadjuvant immunochemotherapy (NICT) has emerged as a promising alternative. Achieving pathological complete response (pCR) after neoadjuvant therapy is associated with favorabl...

Pin-Hao Fang, Xin Xiao, Cheng-Yi Mao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.